Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Revenue

Tonix Pharmaceuticals Holding had revenue of $3.29M in the quarter ending September 30, 2025, with 16.58% growth. This brings the company's revenue in the last twelve months to $10.30M, down -8.79% year-over-year. In the year 2024, Tonix Pharmaceuticals Holding had annual revenue of $10.09M with 29.94% growth.

• Revenue (ttm): $10.30M
• Revenue Growth: -8.79%
• P/S Ratio: 10.15
• Revenue / Employee: $127,148
• Employees: 81
• Market Cap: 201.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.09M	2.33M	29.94%
Dec 31, 2023	7.77M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-